Evidence map›Paper›PMID 37260387›Full record

ArticleSleep2023

The mystery of gamma-hydoxybutyrate efficacy in narcolepsy type 1.

Thomas S Kilduff

Open access · bronzeAbstract readEditorialComment
In one paragraph

Article in Sleep, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Distinct lateral hypothalamic CaMKIIα neuronal populations regulate wakefulness and locomotor activity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas S KilduffCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA, USA.ORCID 0000-0002-6823-0094
SRI International · US

Funding

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERYR01HL059658 · NHLBI · STANFORD UNIVERSITY · PI KILDUFF, THOMAS S · 1997 to 2023
$8.7M
TAAR1-Alzheimers SupplementR01NS103529 · NINDS · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 2018 to 2022
$3.8M
Sleep, opiate withdrawal and the N/OFQ - NOP systemR01HL150836 · NHLBI · SRI INTERNATIONAL · PI BRUCHAS, MICHAEL R., KILDUFF, THOMAS S · 2019 to 2019
$2.0M
Nociceptin/Orphanin FQ, NOPR and Sleep/WakeR21NS113589 · NINDS · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 2020 to 2020
$646k
NHLBI NIH HHS R01 HL059658NHLBI NIH HHS R01 HL150836NINDS NIH HHS R01 NS103529NINDS NIH HHS R21 NS113589
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CataplexyNarcolepsyHumans

Identifiers

PMID37260387
PMCPMC10485562
OpenAlexW4378953378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.